Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to manufacture and export semaglutide to non-patent countries until March 2026
Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to manufacture and export semaglutide to non-patent countries until March 2026 by Soban News (international And National News)
